Düsseldorf, Germany

Friederike Stoll

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 9.7

ph-index = 5

Forward Citations = 115(Granted Patents)


Location History:

  • Düsseldorf, DE (2011 - 2016)
  • Dusseldorf, DE (2018 - 2019)
  • Duesseldorf, DE (2012 - 2022)

Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Exploring the Innovation Path of Inventor Friederike Stoll

Introduction:

Friederike Stoll, a prolific inventor based in Düsseldorf, Germany, has contributed significantly to the field of pharmaceuticals with a remarkable portfolio of 23 patents. Her expertise in developing novel compounds for the treatment and prevention of diseases, particularly in the cardiovascular domain, has garnered widespread recognition in the industry.

Latest Patents:

Among her recent patents is the groundbreaking work on "Branched 3-phenylpropionic acid derivatives and their use." These innovative compounds feature a branched or cyclic alkyl substituent in the 3-position, showcasing Stoll's commitment to advancing therapeutic solutions for complex medical conditions. The applications of these derivatives extend to the development of medication for cardiovascular diseases, underscoring their potential impact on enhancing patient care.

Career Highlights:

Stoll has made significant contributions to renowned companies such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. Her tenure at these organizations has been marked by a relentless pursuit of innovation, leading to the successful filing of multiple patents that have the potential to transform the pharmaceutical landscape.

Collaborations:

Throughout her career, Stoll has collaborated closely with esteemed professionals in the field, including Johannes-Peter Stasch and Karl-Heinz Schlemmer. These collaborations have not only enriched her own research endeavors but have also fostered a culture of knowledge exchange and interdisciplinary cooperation within the industry.

Conclusion:

Inventor Friederike Stoll's dedication to advancing pharmaceutical innovation stands as a testament to her unwavering commitment to improving healthcare outcomes. Through her groundbreaking patents and fruitful collaborations, she continues to shape the future of medical treatment modalities, leaving a lasting impact on the field of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…